Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant
Bevacizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only...